Phio Pharmaceuticals Corp.
Reduced size self-delivering nucleic acid compounds targeting long non-coding RNA
Last updated:
Abstract:
The present disclosure relates to RNAi constructs with improved cellular uptake characteristics and methods of use of these compounds for silencing expression of long coding RNAs (IncRNAs).
Status:
Grant
Type:
Utility
Filling date:
19 Oct 2016
Issue date:
1 Jun 2021